WebCoyote Bioscience is an innovator dedicated to developing point-of-care testing (POCT) solutions and fully automated, integrated rapid molecular diagnostic systems. We fulfill our social responsibility by protecting public health with leading-edge technologies, including our proprietary parallel molecular reaction solution. WebMar 31, 2024 · Junshi Biosciences was the first Chinese pharmaceutical company that obtained marketing approval for anti-PD-1 monoclonal antibody in China. Its first-in-human anti-BTLA antibody for solid tumors...
Liquid Biopsy Market Size, Share & Growth Analysis Report - BCC …
WebAssignee: CYGNUS BIOSCIENCES (BEIJING) CO., LTD. Inventors: Yanyi Huang, Zitian Chen, Wenxiong Zhou, Haifeng Duan, Li Kang, Shuo Qiao TRACK ONE: METHODS FOR OBTAINING AND CORRECTING BIOLOGICAL SEQUENCE INFORMATION. Publication number: 20240251831 ... WebNov 15, 2024 · November 14, 2024 -- Cygnus Biosciences, a Beijing company developing a novel sequencing technology, raised $19.6 million in a B Round. Cygnus is built on sequencing breakthroughs that it acquired from a Peking University team. Combining an innovative fluorogenic sequencing method with an information theory error-correction … great mlb catches
Haifeng Duan Inventions, Patents and Patent Applications - Justia ...
WebNov 6, 2024 · The team has licensed the technology to startup Cygnus Biosciences and is working with the firm to increase its throughput and commercialize it. ... The researchers have filed for patents on the technology and licensed it to Cygnus Biosciences, a Beijing-based startup, and are collaborating with the company to develop a higher throughput ... WebMonitoring sample areas is the basis of ecological management. Songshan National Nature Reserve is one of the most important components of the ecosystem of the central metropolitan area of Beijing, and has fallen behind in its monitoring technology and methods. So, updating the existing equipment and technology is necessary. The current … WebNov 18, 2024 · Chinese gene sequencing company, Cygnus Biosciences has raised $19.6 million series B round from Zhongguancun Development Group and Dongfang Yirui … flood preparation qld